DABCO-catalyzed one-pot three component synthesis of dihydropyrano[3,2-c]chromene substituted quinazolines and their evaluation towards anticancer activity.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2016-08-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2016.07.003PMID 27432765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly chemo- and regioselective allylic substitution with tautomerizable heteroarenes

  2015cited by this paper
• Recent developments in the chemistry of quinazolinone alkaloids.

  2015cited by this paper
• Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.

  2015cited by this paper
• Quinazoline derivatives as anticancer drugs: a patent review (2011 – present)

  2015cited by this paper
• Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer.

  2013cited by this paper
• Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes

  2012cited by this paper
• Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.

  2012cited by this paper
• Therapeutic reactivation of mutant p53 protein by quinazoline derivatives

  2012cited by this paper
• Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).

  2011cited by this paper
• Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.

  2010cited by this paper
• Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).

  2009cited by this paper
• Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration.

  2009cited by this paper
• Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents.

  2008cited by this paper
• Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV.

  2007cited by this paper
• Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series.

  2006cited by this paper
• The Chemistry of Recently Isolated Naturally Occurring Quinazolinone Alkaloids

  2006cited by this paper
• Diazabicyclo[2.2.2]octane - DABCO

  2004cited by this paper
• Recent advances in the Baylis-Hillman reaction and applications.

  2003cited by this paper
• A polymer-bound iminophosphorane approach for the synthesis of quinazolines.

  2001cited by this paper
• Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP).

  1998cited by this paper
• Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists.

  1998cited by this paper
• N-substituted-2-oxo-(2H)1-benzopyran-3-carboxamide derivatives with analgesic and/or diuretic activities.

  1995cited by this paper
• Synthesis and pharmacological activity of 2-oxo-(2H) 1-benzopyran-3-carboxamide derivatives

  1993cited by this paper
• Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators.

  1990cited by this paper

• TiO2@Metal organic framework Ni2(BDC)2(DABCO) as an efficient water splitting heterogeneous photocatalyst for enhanced green hydrogen generation under visible light

  2025cites this paper
• One-pot synthesis of tricyclic pyrano[3.2-c]chromene derivatives and their evaluation through in vitro immunomodulatory activity against T cells; Molecular docking investigations and ADME-Tox prediction studies

  2024cites this paper
• Design, Synthesis, Spectral Characterization, in silico ADMET Studies, Molecular Docking, Antimicrobial Activity, and Anti Breast Cancer Activity of 5,6-dihydrobenzo[H]quinazolines

  2023cites this paper
• Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies

  2023cites this paper
• Therapeutic potential of 4-substituted coumarins: A conspectus

  2022cites this paper
• Comprehensive Review on the Bis–heterocyclic Compounds and their Anticancer Efficacy

  2022cites this paper
• Quinazolinone-based hybrids with diverse biological activities: A mini-review

  2022cites this paper
• Synthesis and Cytotoxic Studies of Quinazoline-Triazole Hybrid Aza Heterocycles

  2021cites this paper
• A Green, Novel and Efficient Protocol for the Preparation of Diverse 4H-Pyrans: The First Report on the Catalytic Activity of Water Extract of Elaeagnus angustifolia Leaves in Organic Reactions

  2020cites this paper
• Synthesis of Biologically Active Molecules through Multicomponent Reactions

  2020cites this paper
• DABCO as a Base and an Organocatalyst in Organic Synthesis: A Review

  2020cites this paper
• Coumarin-containing hybrids and their anticancer activities.

  2019cites this paper
• The molecular diversity scope of 4-hydroxycoumarin in the synthesis of heterocyclic compounds via multicomponent reactions

  2019cites this paper
• An overview of quinazolines: Pharmacological significance and recent developments.

  2018cites this paper
• Green Synthesis of Pyrano[2,3-c]pyrazoles and Spiro[indoline-3,4′-pyrano[2,3-c]pyrazoles] Using Nano-silica Supported 1,4-Diazabicyclo[2.2.2]octane as a Novel Catalyst

  2018cites this paper
• Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-c]chromene derivatives following hetero-Diels–Alder reaction and in vitro anticancer studies

  2018cites this paper
• One-pot three-component protocol for the synthesis of indolyl-4H-chromene-3-carboxamides as antioxidant and antibacterial agents

  2017cites this paper
• Synthesis, X-ray crystal structure and highly non-linear optical properties of inorganic-organic hybrid compound: 1,4-Diazbicyclo-octane oxonium tri- nitrates single crystal

  2017cites this paper
• Quinazolines and anticancer activity: A current perspectives

  2017cites this paper
• An insight into the therapeutic potential of quinazoline derivatives as anticancer agents.

  2017cites this paper
• Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.

  2017cites this paper
• 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction

  2017cites this paper